Nextech Invest Ltd. - Q4 2021 holdings

$380 Million is the total value of Nextech Invest Ltd.'s 11 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
NewEQRX INC$89,372,00013,104,424
+100.0%
23.54%
RVMD NewREVOLUTION MEDICINES INC$74,710,0002,968,214
+100.0%
19.68%
KNTE NewKINNATE BIOPHARMA INC$53,306,0003,008,243
+100.0%
14.04%
NewTYRA BIOSCIENCES INC$35,436,0002,518,582
+100.0%
9.34%
PMVP NewPMV PHARMACEUTICALS INC$32,012,0001,385,807
+100.0%
8.43%
ARVN NewARVINAS INC$23,595,000287,251
+100.0%
6.22%
KRON NewKRONOS BIO INC$19,726,0001,451,537
+100.0%
5.20%
CGEM NewCULLINAN ONCOLOGY INC$18,842,0001,221,145
+100.0%
4.96%
SBTX NewSILVERBACK THERAPEUTICS INC$12,721,0001,910,029
+100.0%
3.35%
CCCC NewC4 THERAPEUTICS INC$12,103,000375,857
+100.0%
3.19%
NewTHESEUS PHARMACEUTICALS INC$7,751,000611,310
+100.0%
2.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
REVOLUTION MEDICINES INC8Q3 202344.0%
EQRX INC8Q3 202323.5%
TYRA BIOSCIENCES INC8Q3 202316.9%
KINNATE BIOPHARMA INC8Q3 202314.0%
CULLINAN ONCOLOGY INC8Q3 20235.3%
PMV PHARMACEUTICALS INC8Q3 20238.4%
ARVINAS INC8Q3 20236.2%
SILVERBACK THERAPEUTICS INC8Q3 20236.5%
KRONOS BIO INC8Q3 20235.2%
THESEUS PHARMACEUTICALS INC8Q3 20232.3%

View Nextech Invest Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-01
13F-HR/A2022-05-16
13F-HR2022-05-16
13F-HR2022-02-14

View Nextech Invest Ltd.'s complete filings history.

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Nextech Invest Ltd.'s holdings